rss
BMJ Case Reports 2010; doi:10.1136/bcr.02.2010.2780
  • Findings that shed new light on the possible pathogenesis of a disease or an adverse effect

Dependence and psychosis with 4-methylmethcathinone (mephedrone) use

  1. S Wylie2
  1. 1Department of General Adult Psychiatry, Falkirk Royal Infirmary, Falkirk, UK
  2. 2Eriskay House, Stobhill Hospital, Glasgow, UK
  1. Correspondence to N Bajaj, nbajaj{at}doctors.org.uk

Summary

‘Legal highs’ are recreational drugs sold over the internet and the so-called ‘head shops’ all over the UK. They are freely available to buy and use as they are not covered by the Misuse of Drugs Act 1971. Mephedrone (4-methylmethcathinone) was sold as a ‘legal high’ until 17 April 2010 when it was made a class B drug under the Misuse of Drugs Act 1971. Numerous deaths and self-harm has been associated with mephedrone use. Effects of mephedrone are reported to be empathogenic similar to 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and stimulant properties similar to cocaine. Not much is known of the effects of mephedrone on mental health. We present a case of dependence and psychosis in a patient using mephedrone (4-methylmethcathinone). The patient needed inpatient hospital care, was treated with antipsychotic olanzapine and recovered well.

Footnotes

  • Competing interests None.

  • Patient consent Obtained.

Register for free content

The full text of all Editor's Choice articles and summaries of every article are free without registration

The full text of Images in ... articles are free to registered users

Only fellows can access the full text of case reports (apart from Editor's Choice) - become a fellow today, or encourage your institution to, so that together we can grow and develop this resource

Don't forget to sign up for content alerts so you keep up to date with all the case reports as they are published, and let us know what you think by commenting on the Editor's blog

Navigate This Article